COMPAMIR
High-Purity Fact Pipeline
High-Purity Fact Pipeline
University of Florida researchers (Ramon Sun, Yi Guo, Jiang Bian)
United States
June 10, 2026
Verified: June 10, 2026
"University of Florida study suggests glucosamine use is associated with a 25% higher risk of dementia progression in patients with mild cognitive impairment. Research indicates glucosamine may increase sugar-tagging of proteins in the brain, potentially worsening metabolic dysfunction in Alzheimer's patients. Findings are based on AI analysis of health records and mouse models; clinical trials are needed to confirm causality."
Author: Amy Berger
This book provides a deep dive into the metabolic theory of Alzheimer's disease, explaining how glucose metabolism and insulin resistance in the brain are central to cognitive decline. It helps readers understand the biochemical context of why substances affecting sugar metabolism, like glucosamine, might have significant implications for brain health.
As an Amazon Associate, COMPAMIR earns from qualifying purchases.